Home » Stocks » INGN

Inogen, Inc. (INGN)

Stock Price: $66.76 USD 1.41 (2.16%)
Updated May 11, 2021 4:00 PM EDT - Market closed
After-hours: $67.25 +0.49 (0.73%) May 11, 5:15 PM
Market Cap 1.49B
Revenue (ttm) 306.93M
Net Income (ttm) -4.97M
Shares Out 22.18M
EPS (ttm) -0.23
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 11
Last Price $66.76
Previous Close $65.35
Change ($) 1.41
Change (%) 2.16%
Day's Open 64.00
Day's Range 64.00 - 66.95
Day's Volume 111,165
52-Week Range 26.57 - 69.00

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Inogen (INGN) gains traction from revenue growth within its Rental segment in Q1.

6 days ago - Zacks Investment Research

Inogen (INGN) delivered earnings and revenue surprises of 89.29% and 8.44%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 week ago - Zacks Investment Research

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for ...

1 week ago - Business Wire

Rebound in base sales make us optimistic about OMI, INGN, XRAY and CNTG's results this time around.

Other stocks mentioned: BSX, CNTG, HOLX, LH, OMI, XRAY
1 week ago - Zacks Investment Research

Inogen (NASDAQ:INGN) unveils its next round of earnings this Tuesday, May 04. Get prepared with Benzinga's ultimate preview for Inogen's Q1 earnings.

1 week ago - Benzinga

As of late, it has definitely been a great time to be an investor in Inogen, Inc. (INGN).

1 week ago - Zacks Investment Research

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first ...

3 weeks ago - Business Wire

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Dir...

1 month ago - Business Wire

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's ma...

1 month ago - Business Wire

Inogen (INGN) reported earnings 30 days ago. What's next for the stock?

1 month ago - Zacks Investment Research

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's ma...

1 month ago - Business Wire

Inogen's (INGN) fourth-quarter results benefit from higher rental revenues and strength in business-to-business revenues.

2 months ago - Zacks Investment Research

Inogen (INGN) delivered earnings and revenue surprises of 17.86% and 6.92%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Shares of Inogen (NASDAQ:INGN) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 483.33% year over year to ($0.23), which beat the estima...

2 months ago - Benzinga

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for ...

2 months ago - Business Wire

Inogen (NASDAQ:INGN) announces its next round of earnings this Wednesday, February 24. Here is Benzinga's everything-that-matters guide for this Wednesday's Q4 earnings announcement.

2 months ago - Benzinga

Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that Kristen Miranda ...

2 months ago - Business Wire

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's ma...

3 months ago - Business Wire

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release fourth...

3 months ago - Business Wire

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Dir...

3 months ago - Business Wire

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's ma...

4 months ago - Business Wire

Inogen (INGN) reported earnings 30 days ago. What's next for the stock?

5 months ago - Zacks Investment Research

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's ma...

6 months ago - Business Wire

Inogen (INGN) saw revenue decline within its Sales segment in Q3

6 months ago - Zacks Investment Research

Inogen Inc. (INGN) CEO Scott Wilkinson on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

Inogen Inc (INGN) CEO Scott Wilkinson on Q2 2020 Results - Quick Version Earnings Call Transcript

6 months ago - Seeking Alpha

Inogen (INGN) delivered earnings and revenue surprises of -300.00% and -0.82%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for ...

6 months ago - Business Wire

Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release third ...

6 months ago - Business Wire

Inogen (INGN) reported earnings 30 days ago. What's next for the stock?

8 months ago - Zacks Investment Research

Investor confidence is high on Inogen (INGN) stock, thanks to solid prospects

8 months ago - Zacks Investment Research

Inogen (INGN) saw growth in revenues within its Rental segment in Q2.

9 months ago - Zacks Investment Research

Inogen Inc (INGN) CEO Scott Wilkinson on Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

Inogen (INGN) delivered earnings and revenue surprises of 250.00% and -10.08%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

Shares of Inogen (NASDAQ:INGN) were flat in after-market trading after the company reported Q2 results.

9 months ago - Benzinga

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc.

9 months ago - Business Wire

Inogen has been a real boom and bust story in terms of its stock price in recent years.

9 months ago - Seeking Alpha

Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

9 months ago - Zacks Investment Research

Inogen: Backdoor Bet On Travel

9 months ago - Seeking Alpha

Inogen (INGN) reported earnings 30 days ago. What's next for the stock?

11 months ago - Zacks Investment Research

Inogen (INGN) reported growth in business-to-business international and domestic revenues in Q1.

1 year ago - Zacks Investment Research

Inogen, Inc. (INGN) CEO Scott Wilkinson on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Inogen (INGN) delivered earnings and revenue surprises of 36.36% and 6.69%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

Investor confidence is high on Inogen (INGN) stock, thanks to solid prospects.

1 year ago - Zacks Investment Research

Oxygen therapy has emerged as a necessity for COVID-19 patients.

Other stocks mentioned: IVC, VAPO
1 year ago - Zacks Investment Research

Inogen (INGN) reported earnings 30 days ago. What's next for the stock?

1 year ago - Zacks Investment Research

Inogen (INGN) expects to report a loss per share in the first quarter of 2020.

1 year ago - Zacks Investment Research

About INGN

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrat... [Read more...]

Industry
Medical Devices
IPO Date
Feb 14, 2014
CEO
Scott Wilkinson
Employees
938
Stock Exchange
NASDAQ
Ticker Symbol
INGN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for Inogen stock is "Hold." The 12-month stock price forecast is 69.00, which is an increase of 3.36% from the latest price.

Price Target
$69.00
(3.36% upside)
Analyst Consensus: Hold